The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Herrmann, N.
* Articles by Campbell, B.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Herrmann, N.
* Articles by Campbell, B.
Related Collections
* Dementias (General)
J Neuropsychiatry Clin Neurosci 10:220-223, May 1998
© 1998 American Psychiatric Press, Inc.


Clinical and Research Report

Risperidone for the Treatment of Behavioral Disturbances in Dementia

A Case Series

Nathan Herrmann, M.D., F.R.C.P.C., Marie-France Rivard, M.D., F.R.C.P.C., Michael Flynn, M.D., F.R.C.P.C., Carol Ward, M.D., F.R.C.P.C., Kiran Rabheru, M.D., F.R.C.P.C. and Barry Campbell, M.D., F.R.C.P.C.

Received January 13, 1997; revised March 24, 1997; accepted April 9, 1997. From Sunnybrook Health Science Centre, University of Toronto; Royal Ottawa Hospital, University of Ottawa; The Nova Scotia Hospital, Dalhousie University, Halifax, Nova Scotia; London Psychiatric Hospital, London, Ontario; and St. Boniface General Hospital, Winnipeg, Manitoba, Canada. Address correspondence to Dr. Herrmann, Division of Geriatric Psychiatry, Sunnybrook Health Science Centre, 2075 Bayview Avenue, Room FG20, North York, ON M4N 3M5, Canada; e-mail: n.herrmann{at}utoronto.ca

The authors describe a series of 22 patients with dementia and behavioral disturbances, including agitation, aggression, delusions, and hallucinations, who were treated with risperidone. Risperidone, in low doses, was well tolerated; 50% of patients experienced significant improvement, although 50% experienced some extrapyramidal symptoms.

Key Words: Risperidone • Behavioral Disturbance • Dementia




This article has been cited by other articles:


Home page
J Clin PharmacolHome page
Q. Zhao, C. Xie, L. Pesco-Koplowitz, X. Jia, and J.-L. Parier
Pharmacokinetic and Safety Assessments of Concurrent Administration of Risperidone and Donepezil
J. Clin. Pharmacol., February 1, 2003; 43(2): 180 - 186.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
K. L. Lanctôt, N. Herrmann, and P. Mazzotta
Role of Serotonin in the Behavioral and Psychological Symptoms of Dementia
J Neuropsychiatry Clin Neurosci, February 1, 2001; 13(1): 5 - 21.
[Abstract] [Full Text]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
M. Simard, R. van Reekum, and T. Cohen
A Review of the Cognitive and Behavioral Symptoms in Dementia With Lewy Bodies
J Neuropsychiatry Clin Neurosci, November 1, 2000; 12(4): 425 - 450.
[Abstract] [Full Text]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
D. M. Roane, T. E. Feinberg, L. Meckler, C. R. Miner, A. Scicutella, and R. N. Rosenthal
Treatment of Dementia-Associated Agitation With Gabapentin
J Neuropsychiatry Clin Neurosci, February 1, 2000; 12(1): 40 - 43.
[Abstract] [Full Text]


Home page
NeurologyHome page
P. I. Rosebush and M. F. Mazurek
Neurologic side effects in neuroleptic-naive patients treated with haloperidol or risperidone
Neurology, March 1, 1999; 52(4): 782 - 782.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1998 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org